{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:49:58Z","timestamp":1779176998760,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":87,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bone.2025.117578","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T01:33:39Z","timestamp":1751765619000},"page":"117578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The number of vertebral fractures in indolent systemic mastocytosis is influenced by presence of the KIT-mutation"],"prefix":"10.1016","volume":"200","author":[{"given":"Christof","family":"Wilke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Lamersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Undine","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2025.117578_bb0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bone.2025.117578_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00223-021-00887-4","article-title":"Osteoporosis caused by systemic mastocytosis: prevalence in a cohort of 8392 patients with osteoporosis","volume":"109","author":"Gehlen","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2025.117578_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002920000439","article-title":"Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis of 158 cases","volume":"22","author":"Delling","year":"2001","journal-title":"Pathologe"},{"issue":"3","key":"10.1016\/j.bone.2025.117578_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.bone.2025.117578_bb0025","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.jaip.2024.08.044","article-title":"Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM","volume":"12","author":"Valent","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.bone.2025.117578_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00105-016-3911-2","article-title":"Mastocytosis: clinical aspects, diagnostics, therapy","volume":"68","author":"Lippert","year":"2017","journal-title":"Hautarzt"},{"issue":"21","key":"10.1016\/j.bone.2025.117578_bb0035","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.18632\/oncotarget.4213","article-title":"Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder","volume":"6","author":"Chatterjee","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bone.2025.117578_bb0040","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00198-019-04918-7","article-title":"Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome","volume":"30","author":"Degbo\u00e9","year":"2019","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2025.117578_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","article-title":"High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis","volume":"67","author":"van der Veer","year":"2012","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.bone.2025.117578_bb0050","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2014.05.003","article-title":"Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis","volume":"134","author":"van der Veer","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.bone.2025.117578_bb0055","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","article-title":"Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis","volume":"24","author":"Seitz","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2025.117578_bb0060","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00198-016-3539-1","article-title":"Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis","volume":"27","author":"Rossini","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"12","key":"10.1016\/j.bone.2025.117578_bb0065","first-page":"684","article-title":"Osteoporosis - implications of the new guidelines in practice","volume":"149","author":"Siggelkow","year":"2024","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2025.117578_bb0070","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00198-002-1348-1","article-title":"Assessment of prevalent and incident vertebral fractures in osteoporosis research","volume":"14","author":"Genant","year":"2003","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2025.117578_bb0075","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.bone.2025.117578_bb0080","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jaip.2022.05.036","article-title":"Standards of pathology in the diagnosis of systemic mastocytosis: recommendations of the EU-US cooperative group","volume":"10","author":"Sotlar","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.bone.2025.117578_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01605979","article-title":"Enzyme and immunohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic: a new embedding method for routine application","volume":"420","author":"Wolf","year":"1992","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"issue":"8","key":"10.1016\/j.bone.2025.117578_bb0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamainternmed.2021.2617","article-title":"Risk of subsequent fractures in postmenopausal women after nontraumatic vs traumatic fractures","volume":"181","author":"Crandall","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"7","key":"10.1016\/j.bone.2025.117578_bb0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.injury.2015.04.008","article-title":"Cigarette smoking and risk of hip fracture in women: a meta-analysis of prospective cohort studies","volume":"46","author":"Shen","year":"2015","journal-title":"Injury"},{"issue":"7","key":"10.1016\/j.bone.2025.117578_bb0100","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bone.2025.117578_bb0105","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bone.2025.117578_bb0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-015-9969-5","article-title":"Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis","volume":"96","author":"Rossini","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2025.117578_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00163","article-title":"The role of mast cells in bone metabolism and bone disorders","volume":"11","author":"Ragipoglu","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bone.2025.117578_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajh.26118","article-title":"Systemic mastocytosis in adults: 2021 update on diagnosis, risk stratification and management","volume":"96","author":"Pardanani","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.bone.2025.117578_bb0125","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human kit receptor with the activating Asp816Val mutation","volume":"202","author":"Zappulla","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bone.2025.117578_bb0130","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit","volume":"117","author":"Gerbaulet","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bone.2025.117578_bb0135","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2005.02.030","article-title":"Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature","volume":"115","author":"Kocabas","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bone.2025.117578_bb0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2013.02.019","article-title":"KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis","volume":"132","author":"Broesby-Olsen","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2025.117578_bb0145","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","article-title":"Systemic mastocytosis and bone involvement in a cohort of 75 patients","volume":"69","author":"Barete","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2025.117578_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bone.2017.09.005","article-title":"Prevalence and risk factors for fragility fracture in systemic mastocytosis","volume":"105","author":"Degbo\u00e9","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2025.117578_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","article-title":"Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis","volume":"49","author":"Rossini","year":"2011","journal-title":"Bone"},{"issue":"20","key":"10.1016\/j.bone.2025.117578_bb0160","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.298.20.2381","article-title":"High-trauma fractures and low bone mineral density in older women and men","volume":"298","author":"Mackey","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.bone.2025.117578_bb0165","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"7041","key":"10.1016\/j.bone.2025.117578_bb0170","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.bone.2025.117578_bb0175","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jaip.2023.02.007","article-title":"Bone and cytokine markers associated with bone disease in systemic mastocytosis","volume":"11","author":"Rama","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.bone.2025.117578_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study","volume":"34","author":"Schuit","year":"2004","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2025.117578_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2025.117578_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116753","article-title":"Bone parameters in T1D and T2D assessed by DXA and HR-pQCT - a cross-sectional study: the DIAFALL study","volume":"172","author":"Rasmussen","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117578_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1111020","article-title":"2D-3D reconstruction of the proximal femur from DXA scans: evaluation of the 3D-shaper software","volume":"11","author":"Dudle","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bone.2025.117578_bb0200","doi-asserted-by":"crossref","first-page":"75.e1","DOI":"10.1016\/j.amjmed.2012.07.018","article-title":"Bone complications of mastocytosis: a link between clinical and biological characteristics","volume":"126","author":"Guillaume","year":"2013","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.bone.2025.117578_bb0205","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.bone.2025.117578_bb0210","first-page":"258","article-title":"The clinical features of hereditary alpha-tryptasemia-implications for interdisciplinary practice","volume":"121","author":"von Bubnoff","year":"2024","journal-title":"Dtsch. Arztebl. Int."},{"issue":"7","key":"10.1016\/j.bone.2025.117578_bb0215","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jaip.2024.04.027","article-title":"Non-skin related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from the chronic urticaria registry","volume":"12","author":"Pyatilova","year":"2024","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:47:13Z","timestamp":1769575633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S8756328225001905"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117578","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The number of vertebral fractures in indolent systemic mastocytosis is influenced by presence of the KIT-mutation","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117578"}}